| Model Number |
D-EVOLUTFX-2329 |
| Medical Device Problem Code |
Patient Device Interaction Problem (4001)
|
| Health Effect - Clinical Code |
Retroperitoneal Hemorrhage (4483)
|
| Date of Event |
08/26/2026
|
|
Type of Reportable Event
|
Death
|
|
Event or Problem Description
|
|
It was reported that following the implant of a transcatheter aortic valve through the femoral access site, the patient experienced retroperitoneal bleeding and died.Per the physician, the retroperitoneal bleeding was the cause of death and the patient anatomy, including a large pannus, were identified as contributing factors.
|
| |
|
Event or Problem Description
|
|
Additional information was received indicating that per the physician, the cause of the retroperitoneal bleeding was perclose failure and inability to maintain homeostasis.Per the physician, the delivery catheter system (dcs) did not cause or contribute to the retroperitoneal bleeding.
|
| |
|
Additional Manufacturer Narrative
|
|
D10.Continuation - concomitant medical devices in use during the event include: medtronic product id:evfxplus-26 ; product serial/lot number: r502941; product type: 0195- heart valves; implant date: (b)(6)2026; explant date: na; medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Additional Manufacturer Narrative
|
|
Updated: a4, b2, b3, b5, d4, h4.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|